No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1257 |
4. Check minimum number of eventsNone |
1257 |
5. Include endpointsNone |
1257 |
6. Filter based on genotype QC (FinnGen only) |
1257 |
Control definitions (FinnGen only)
- Control exclude
- H7_OCUMUSCLE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H50
- Name in latin
- Strabismus verticalis
Similar endpoints
↥List of similar endpoints to
Vertical strabismus
based on the number of shared cases.
Similar with more cases:
- Other strabismus
- Strabismus
- Disorders of ocular muscles, binocular movement, accommodation and refraction
- Diseases of the eye and adnexa
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 9645 | 5200 | 4422 |
| Only index persons | 8778 | 4806 | 3972 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.14 | 0.15 | 0.12 |
| Only index persons | 0.17 | 0.18 | 0.15 |
| Median age at first event (years) | |||
| Whole population | 28.68 | 28.55 | 28.72 |
| Only index persons | 30.56 | 30.52 | 30.61 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1257 | 758 | 499 |
| Unadjusted period prevalence (%) | 0.24 | 0.26 | 0.22 |
| Median age at first event (years) | 47.02 | 42.89 | 53.30 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1143
- Matched controls
- 11430
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H50.2
ICD-10 Finland
Vertical strabismus
4503599627370496.0
323.0
902
*
H53.2
ICD-10 Finland
Diplopia
41.2
202.3
255
79
CEC00
NOMESCO Finland
Recession of extraocular muscle
+∞
181.2
169
*
37302
ICD-8 Finland
Strabismus, Concomitans sursum sive deorsum vergens
+∞
174.6
163
*
H50.1
ICD-10 Finland
Divergent concomitant strabismus
1463.8
136.3
130
*
CEC10
NOMESCO Finland
Recession and resection of extraocular muscle
+∞
135.1
127
*
H49.1
ICD-10 Finland
Fourth [trochlear] nerve palsy
1325.4
124.4
119
*
H50.0
ICD-10 Finland
Convergent concomitant strabismus
+∞
121.0
114
*
3783A
ICD-9 Finland
Strabismus and other disorders of binocular eye movements, Other and unspecified heterotropia
+∞
115.6
109
*
3503
FHL
Single muscle retroposition
+∞
101.6
96
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
6.0
90.4
282
594
H50.52
ICD-10 Finland
Exophoria
443.9
84.2
83
*
H50.31
ICD-10 Finland
Intermittent exotropia
+∞
72.7
69
*
37300
ICD-8 Finland
Strabismus, Concomitans convergens
+∞
71.6
68
*
CEC60
NOMESCO Finland
Transposition of extraocular muscle with adjustable suture
+∞
64.2
61
*
H06.2*E05.9
ICD-10 Finland
Dysthyroid exophthalmos
60.7
63.5
74
13
CEW99
NOMESCO Finland
Other operation on extraocular muscle
+∞
63.1
60
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.4
47.8
273
969
37301
ICD-8 Finland
Strabismus, Concomitans divergens
+∞
47.2
45
*
H50.8
ICD-10 Finland
Other specified strabismus
+∞
41.9
40
*
H50.30
ICD-10 Finland
Intermittent esotropy
+∞
40.9
39
*
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
7.8
39.8
95
132
H50.9
ICD-10 Finland
Strabismus, unspecified
185.6
34.9
36
*
XCK00
NOMESCO Finland
Perimetry
4.4
34.3
132
328
H52.0
ICD-10 Finland
Hypermetropia
35.1
34.3
44
13
CEC30
NOMESCO Finland
Resection of extraocular muscle
+∞
33.5
32
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.2
32.9
496
2966
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
41.4
32.3
40
10
CEC20
NOMESCO Finland
Recession and advancement of extraocular muscle
+∞
31.4
30
*
CE2W4
NOMESCO Finland
Eye movement mapping
159.1
29.8
31
*
WX140
NOMESCO Finland
Parabulbar anesthesy
5.2
29.6
95
195
H50.4
ICD-10 Finland
Other and unspecified heterotropia
299.2
28.9
29
*
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
19.4
28.4
43
23
H06.2
ICD-10 Finland
Dysthyroid exophthalmos
48.4
27.6
33
7
CEC90
NOMESCO Finland
Total transposition of extraocular muscle or muscles
+∞
27.2
26
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.6
26.8
130
396
H52.1
ICD-10 Finland
Myopia
11.6
24.8
46
41
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.0
24.2
393
2343
H53.0
ICD-10 Finland
Amblyopia ex anopsia
19.5
24.0
36
19
H03BB01
ATC
carbimazole; oral
4.8
23.9
82
181
H50.6
ICD-10 Finland
Mechanical strabismus
+∞
23.0
22
*
3780B
ICD-9 Finland
Strabismus and other disorders of binocular eye movements, Convergent concomitant strabismus[STRABISMUS CONVERGENS ALTERNANS]
+∞
23.0
22
*
H50.50
ICD-10 Finland
Alternating hyperphoria
122.5
22.7
24
*
H52.2
ICD-10 Finland
Astigmatism
21.2
22.6
33
16
3504
FHL
Retroposition of two muscles
+∞
21.9
21
*
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
6.1
21.9
60
102
CEC50
NOMESCO Finland
Advancement of extraocular muscle
+∞
20.9
20
*
H52.3
ICD-10 Finland
Anisometropia and aniseikonia
48.9
20.2
24
5
H05.2
ICD-10 Finland
Exophthalmic conditions
36.5
19.9
25
7
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
+∞
18.8
18
*
ZXA00
NOMESCO Finland
Right side
1.9
18.8
316
1875
H50.51
ICD-10 Finland
Esophoria
71.1
18.8
21
*
N07AA02
ATC
pyridostigmine; systemic
19.1
18.7
28
15
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
3.3
18.7
97
311
H062, E050
ICD-10 Finland
NA
53.4
18.0
21
*
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
+∞
17.7
17
*
3501
FHL
Myotomy or tenotomy
+∞
17.7
17
*
37303
ICD-8 Finland
Strabismus, Heterophoria (exophoria, esophroria, hypophoria)
+∞
17.7
17
*
AA1AD
NOMESCO Finland
CT of head and brain
2.0
17.1
257
1453
3505
FHL
Single muscle resection
+∞
16.7
16
*
3780A
ICD-9 Finland
Strabismus and other disorders of binocular eye movements, Convergent concomitant strabismus[STRABISMUS CONCOMITANS CONVERGENS]
+∞
16.7
16
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.0
16.7
54
113
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.5
15.8
131
563
F95
ICPC
Strabismus
60.9
15.8
18
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
15.7
314
1960
ZXA10
NOMESCO Finland
Bilateral
2.0
15.7
213
1153
G70.0
ICD-10 Finland
Myasthenia gravis
19.5
15.6
23
12
ZXA05
NOMESCO Finland
Left side
1.9
15.3
286
1740
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.3
14.9
146
683
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.6
14.8
115
477
3781B
ICD-9 Finland
Strabismus and other disorders of binocular eye movements, Divergent concomitant strabismus[STRABISMUS DIVERGENS ALTERNANS]
+∞
14.6
14
*
3507
FHL
Retroposition and resection
151.8
14.5
15
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.5
13.7
107
446
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
9.8
13.2
26
27
H51.8
ICD-10 Finland
Other specified disorders of binocular movement
+∞
12.5
12
*
3510
FHL
Cardiac surgery on three or more muscles
+∞
12.5
12
*
H51.1
ICD-10 Finland
Convergence insufficiency and excess
+∞
12.5
12
*
3781A
ICD-9 Finland
Strabismus and other disorders of binocular eye movements, Divergent concomitant strabismus[STRABISMUS CONCOMITANS DIVERGENS]
+∞
12.5
12
*
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
131.4
12.5
13
*
H03AA01
ATC
levothyroxine sodium; systemic
1.8
12.2
257
1612
108
Kela drug reimbursment
Myasthenia gravis
16.1
12.2
19
12
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
21.5
12.0
17
8
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.4
12.0
101
437
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.1
11.9
134
665
XCK10
NOMESCO Finland
Photography of fundus of eye
2.2
11.9
119
563
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
8.0
11.9
26
33
CAC30
NOMESCO Finland
Decompression of orbit to sinuses
65.6
11.6
13
*
3782B
ICD-9 Finland
Strabismus and other disorders of binocular eye movements, Intermittent heterotropia[STRABISMUS DIVERGENS INTERMITTENS]
+∞
11.5
11
*
H02.4
ICD-10 Finland
Ptosis of eyelid
4.2
10.6
39
95
H53.1
ICD-10 Finland
Subjective visual disturbances
2.6
10.6
75
297
TAB00
NOMESCO Finland
Lumbar puncture
3.1
10.4
57
192
H25.0
ICD-10 Finland
Senile incipient cataract
2.8
10.4
65
238
CS494
NOMESCO Finland
Other visual field testing
4.1
10.2
38
94
H04.10
ICD-10 Finland
Dry eye syndrome
2.2
10.0
108
526
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
7.5
9.7
22
30
WX002
NOMESCO Finland
Sedation and analgesia
1.7
9.5
201
1253
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
9.5
306
2143
CEC40
NOMESCO Finland
Resection and advancement of extraocular muscle
+∞
9.4
9
*
3508
FHL
Transposition or anteposition
+∞
9.4
9
*
H53.3
ICD-10 Finland
Other disorders of binocular vision
13.8
9.2
15
11
H26.4
ICD-10 Finland
After-cataract
2.2
9.1
90
424
CJB10
NOMESCO Finland
Laser discission of secondary cataract
2.3
9.0
83
378
CAC10
NOMESCO Finland
Reconstruction of orbital wall using bone graft or plate
37.0
9.0
11
*
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
4.6
9.0
30
67
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
3.5
8.8
40
118
WX402
NOMESCO Finland
General anaesthesia
1.7
8.6
172
1055
CAC44
NOMESCO Finland
Combined decompression of orbit
90.7
8.4
9
*
3784B
ICD-9 Finland
Strabismus and other disorders of binocular eye movements, Heterophoria[EXOPHORIA]
+∞
8.3
8
*
CEC80
NOMESCO Finland
Partial transposition of extraocular muscle
+∞
8.3
8
*
37304
ICD-8 Finland
Strabismus, paralyticus. Paresis nervorum III, IV, VI
+∞
8.3
8
*
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.6
8.2
254
1753
R42
ICD-10 Finland
Dizziness and giddiness
1.6
8.2
211
1388
H33.0
ICD-10 Finland
Retinal detachment with retinal break
3.5
8.1
36
105
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
8.0
104
548
BAA60
NOMESCO Finland
Total thyroidectomy
3.5
7.4
33
97
CAC20
NOMESCO Finland
Lateral decompression of orbit
80.6
7.4
8
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
3.8
7.4
29
77
CEC85
NOMESCO Finland
Combined correction of cyclodeviation
+∞
7.3
7
*
CA1BM
NOMESCO Finland
Eye and orbita MRI examination with 3 Tesla magnet
+∞
7.3
7
*
CEE00
NOMESCO Finland
Posterior fixation suture of extraocular muscle
+∞
7.3
7
*
XA800
NOMESCO Finland
Neuropsychological investigation
2.7
7.2
47
179
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
7.1
525
4314
H35.38
ICD-10 Finland
Preretinal fibrosis of the macula
2.9
7.0
41
146
S02.30
ICD-10 Finland
Fracture of orbital floor, closed
7.0
7.0
16
23
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.2
7.0
66
305
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
6.9
152
956
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
6.7
6.8
16
24
H50.59
ICD-10 Finland
Heterophor UNS
40.3
6.8
8
*
WX110
NOMESCO Finland
Local anesthesy
1.4
6.8
720
6280
A02BC05
ATC
esomeprazole; systemic
1.4
6.7
385
3009
N06AX11
ATC
mirtazapine; oral
1.5
6.7
310
2329
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
4.9
6.7
20
41
XCD00
NOMESCO Finland
Clinical examination of eye in general anaesthesia
22.7
6.7
9
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
6.6
209
1446
R20.2
ICD-10 Finland
Paraesthesia of skin
2.1
6.6
69
337
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.1
6.5
33
109
H50.39
ICD-10 Finland
Intermittent heterotropia
70.2
6.4
7
*
CA1AD
NOMESCO Finland
Orbita CT
14.4
6.4
10
7
J01DB01
ATC
cefalexin; oral
1.4
6.4
857
7747
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
6.3
131
809
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.7
6.3
121
732
TCG00
NOMESCO Finland
Protection of cornea and sclera with soft lens
11.1
6.3
11
10
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.9
6.3
83
444
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
4.3
6.2
21
49
N02AX02
ATC
tramadol; systemic, rectal
1.4
6.2
399
3178
R01AD09
ATC
mometasone; nasal
1.4
6.1
447
3634
H25.1
ICD-10 Finland
Senile nuclear cataract
1.5
6.1
198
1375
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
12.6
6.1
10
8
104
Kela drug reimbursment
Thyroid insufficiency
2.0
6.1
74
385
R62.0
ICD-10 Finland
Delayed milestone
8.6
6.1
12
14
CKC60
NOMESCO Finland
Local buckling of sclera using implant
10.1
6.0
11
11
S18
ICPC
Laceration/cut
1.4
6.0
394
3144
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
63
60
11.00
58.07
1.2
1.1
3.7
1.8
nmol/l
0.35
16
12
106
273
4.15
37.19
3.4
1.9
6.5
4.9
iu/l
0.57
61
101
649
4877
1.68
17.96
6.9
6.7
1.2
1.2
mmol/l
0.41
551
4159
589
4420
1.63
15.60
6.1
6.0
1.2
1.2
mmol/l
0.55
543
4043
408
2884
1.61
13.25
2.2
2.1
219.4
223.8
u/l
0.03
390
2720
128
650
2.08
12.50
4.8
3.3
4.5
4.6
pmol/l
0.48
116
573
256
1721
1.61
9.82
1.8
1.7
1055.3
1180.0
nmol/l
1.50
190
1311
701
5818
1.46
9.79
5.0
4.7
6.5
6.6
mmol/l
0.86
663
5423
1051
9502
1.65
9.64
6.3
4.7
1.8
2.0
mu/l
0.84
979
8768
509
3987
1.46
9.53
2.0
1.9
97.7
95.1
pmol/l
0.63
266
2078
911
8017
1.50
9.01
5.6
4.0
14.9
14.7
pmol/l
1.37
844
7352
530
4231
1.44
8.76
4.5
4.7
36.3
35.8
g/l
1.15
495
3947
55
231
2.44
8.50
2.0
1.8
1046.6
632.5
e6/l
0.23
43
182
55
231
2.44
8.50
2.0
1.7
19.2
15.0
e6/l
0.18
43
174
158
975
1.71
8.38
2.2
2.0
358.9
377.2
nmol/l
0.59
143
900
20
45
4.50
8.38
2.9
2.2
—
—
—
0
0
34
112
3.09
8.32
1.1
1.1
—
—
—
0
0
53
224
2.43
8.09
1.2
1.5
3.7
3.7
mmol/l
0.01
48
212
1114
10335
1.68
7.92
15.4
13.4
21.7
23.1
mg/l
0.61
900
8101
876
7728
1.44
7.91
7.4
7.3
79.7
78.6
u/l
0.17
831
7275
1121
10437
1.68
7.60
17.8
15.1
139.7
139.6
mmol/l
0.68
1101
10164
220
1514
1.55
7.48
1.9
2.2
30.1
29.7
s
0.33
212
1471
1122
10461
1.68
7.41
18.0
15.2
4.0
4.0
mmol/l
0.12
1103
10177
769
6740
1.36
6.47
5.5
4.3
3545.5
2785.6
e6/l
0.11
13
102
221
1571
1.49
6.41
2.7
3.4
0.8
0.8
mmol/l
0.07
207
1479
28
102
2.78
5.81
1.1
1.0
—
—
—
0
0
21
65
3.27
5.74
1.1
1.1
1.1
1.1
u/l
—
8
34
184
1290
1.50
5.68
5.2
5.7
1.1
1.1
mmol/l
0.05
172
1203
417
3393
1.34
5.47
3.2
3.4
2.4
2.4
mmol/l
0.03
356
2996
997
9216
1.40
5.34
5.8
5.4
39.1
39.4
mmol/mol
0.39
932
8610
836
7540
1.32
5.13
4.4
4.0
11.1
11.6
mm/h
0.47
780
6998
76
443
1.76
4.98
1.9
2.2
34.0
39.3
u/l
1.62
70
393
588
5091
1.29
4.73
4.0
3.5
0.0
0.0
estimate
0.28
110
937
500
4244
1.30
4.67
2.5
2.3
76.6
76.1
nmol/l
0.15
450
3837
23
86
2.71
4.60
1.2
1.2
35.8
41.2
mg/l
0.26
18
70
310
2471
1.34
4.54
1.4
1.3
0.9
1.7
u/ml
2.17
92
667
208
1567
1.39
4.35
2.0
1.9
—
—
—
0
0
593
5194
1.27
4.17
5.3
6.1
11.5
11.5
umol/l
0.00
559
4923
147
1051
1.45
4.11
7.8
7.8
5.1
5.1
kpa
0.04
140
1009
147
1052
1.45
4.09
7.8
7.8
12.9
12.3
kpa
0.65
141
1012
575
5025
1.27
4.09
3.9
3.5
0.0
0.0
estimate
0.00
115
953
575
5037
1.26
3.97
5.2
4.8
0.0
0.0
estimate
0.50
112
975
109
739
1.52
3.97
4.0
3.8
73.2
81.7
ng/l
0.56
92
663
760
6880
1.26
3.95
3.2
3.1
44.1
45.7
u/l
0.24
723
6478
368
3056
1.29
3.93
3.4
3.2
7.5
7.6
mmol/l
0.31
323
2581
1037
9775
1.35
3.91
4.7
4.3
5.8
5.9
mmol/l
0.48
964
8964
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
59
2.91
3.91
1.2
1.1
—
—
—
0
0
668
5962
1.26
3.90
9.4
8.8
4.0
4.1
e9/l
0.28
583
5226
549
4809
1.25
3.72
4.0
4.0
—
—
—
0
0
429
3666
1.26
3.57
3.7
3.5
28.9
47.4
ng/l
0.88
290
2415
17
63
2.72
3.50
1.1
1.5
—
—
—
0
0
49
282
1.77
3.44
1.9
2.4
11.5
11.9
mg/l
0.12
42
256
10
27
3.73
3.35
1.0
1.1
—
—
—
0
0
10
27
3.73
3.35
1.0
1.1
—
—
—
0
0
142
1049
1.40
3.34
8.1
7.9
0.5
1.2
mmol/l
1.45
112
831
20
83
2.43
3.31
1.0
1.1
—
—
—
0
0
214
1689
1.32
3.30
2.6
2.7
0.8
1.0
e6/l
1.09
115
946
54
324
1.70
3.29
1.6
1.4
10.9
9.9
u/l
0.14
45
258
66
420
1.60
3.21
1.8
1.5
363.4
294.0
mu/l
0.71
59
373
1068
10181
1.33
3.18
4.8
4.6
2.7
2.8
mmol/l
1.47
994
9449
304
2533
1.26
3.08
2.3
2.2
2.8
3.0
mg/l
0.44
253
2175
1052
10019
1.31
3.07
4.3
4.2
4.6
4.7
mmol/l
1.62
982
9353
15
56
2.70
3.06
1.2
1.1
—
—
—
0
0
11
34
3.26
3.06
2.6
5.3
—
—
—
0
0
1135
10940
1.39
2.97
11.3
9.9
26.0
26.2
u/l
0.14
1100
10598
202
1605
1.31
2.96
2.7
2.9
2.9
2.6
e6/l
0.14
105
866
104
747
1.43
2.89
1.3
1.2
174.2
153.2
iu/ml
0.21
47
302
37
207
1.81
2.89
1.4
1.4
—
—
—
0
0
37
207
1.81
2.89
1.4
1.4
—
—
—
0
0
295
2471
1.25
2.84
2.7
2.6
2366.8
6011.8
umol/l
1.43
258
2160
8
18
4.47
2.79
1.8
1.3
—
—
—
0
0
1010
9600
1.27
2.78
3.8
3.8
1.3
1.3
mmol/l
0.02
931
8871
82
567
1.48
2.78
1.7
1.6
—
—
—
0
0
124
925
1.38
2.78
2.2
2.4
26.8
36.0
u/l
2.56
99
785
225
1839
1.27
2.66
3.8
3.7
259.9
359.7
ng/l
0.34
172
1380
167
1313
1.31
2.65
2.0
2.4
194.4
119.9
ug/g
0.66
131
1034
275
2306
1.25
2.61
1.6
1.5
20.5
20.9
nmol/l
0.18
238
1973
1042
9961
1.27
2.60
4.3
4.1
1.4
1.5
mmol/l
1.68
965
9245
764
7078
1.20
2.60
3.3
3.2
—
—
—
0
0
176
1398
1.30
2.60
2.3
2.3
2.4
2.3
g/l
0.75
167
1301
250
2076
1.25
2.58
1.7
1.7
460.4
30778459.9
pmol/l
2.17
212
1748
1002
9539
1.25
2.57
14.3
12.1
84.1
83.6
ml/min/173m2
0.32
815
7796
323
2760
1.23
2.57
3.5
3.1
0.4
0.4
e6/l
0.22
242
2072
1187
11568
1.47
2.54
23.6
19.6
251.6
252.6
e9/l
0.23
1174
11295
91
655
1.42
2.53
3.5
3.8
2.1
1.8
mmol/l
0.47
66
484
247
2055
1.25
2.51
3.1
2.5
4.9
6.4
e6/l
0.98
222
1812
106
788
1.38
2.45
3.5
3.6
1.2
1.2
mmol/l
0.13
96
690
1187
11578
1.45
2.42
23.6
19.6
4.5
4.5
e12/l
0.15
1169
11273
77
543
1.45
2.40
1.4
1.4
25.0
27.2
iu/l
0.22
63
454
1187
11581
1.45
2.38
23.6
19.6
6.7
6.7
e9/l
0.07
1171
11271
1187
11582
1.45
2.37
23.8
19.7
135.7
135.4
g/l
0.36
1178
11426
360
3134
1.21
2.36
2.5
2.5
57.8
56.2
u/l
0.27
336
2904
7
17
4.13
2.36
1.0
1.1
—
—
—
0
0
385
3374
1.20
2.35
3.2
3.2
29.1
32.5
u/l
1.91
366
3212
141
1104
1.31
2.32
1.8
1.8
—
—
—
0
0
15
66
2.29
2.25
1.2
1.2
—
—
—
0
0
9
29
3.12
2.22
1.1
1.2
—
—
—
0
0
145
1148
1.30
2.21
6.6
6.9
—
—
—
0
0
186
1524
1.26
2.16
2.3
2.4
13.1
13.2
umol/l
0.01
177
1412
5
10
5.01
2.07
1.0
1.1
—
—
—
0
0
94
707
1.36
2.05
2.7
2.2
12.4
12.6
nmol/l
0.11
84
630
1006
9645
1.22
2.05
17.7
14.3
39.9
39.9
%
0.00
730
7197
140
1115
1.29
2.05
1.8
1.8
—
—
—
0
0
92
690
1.36
2.05
3.5
3.8
5.4
5.1
kpa
1.28
87
652
51
343
1.51
2.04
2.0
2.8
100.1
91.1
%
1.87
44
321
515
4681
1.17
2.00
3.0
2.8
101.6
111.8
ug/l
0.76
479
4358
307
2673
1.20
1.98
4.5
3.8
0.0
0.0
estimate
1.28
111
941
96
729
1.34
1.98
2.2
3.0
65.6
66.7
g/l
0.75
89
673
282
2444
1.20
1.91
2.3
2.2
—
—
—
0
0
159
1300
1.26
1.89
2.0
1.8
1.4
1.4
%
0.54
135
1160
7
22
3.19
1.88
1.0
1.1
—
—
—
0
0
6
17
3.54
1.84
1.0
1.1
—
—
—
0
0
50
345
1.47
1.80
2.0
1.7
—
—
—
0
0
8
29
2.77
1.79
1.1
1.1
—
—
—
0
0
8
29
2.77
1.79
1.1
1.1
—
—
—
0
0
78
584
1.36
1.78
9.8
9.9
1.5
1.4
%
0.25
78
579
209
1777
1.21
1.74
1.3
1.3
18.3
33.8
iu/ml
2.83
65
544
156
1290
1.24
1.70
2.4
2.4
22.1
23.0
%
0.35
134
1107
77
583
1.34
1.66
9.9
10.0
0.8
0.7
%
0.44
77
578
44
302
1.47
1.65
1.5
1.4
260.4
295.5
ug/g
0.43
24
178
12
56
2.15
1.61
1.1
1.4
—
41.3
—
0
8
13
63
2.07
1.60
2.8
1.8
—
—
—
0
0
44
305
1.46
1.58
2.1
1.8
—
—
—
0
0
264
2314
1.18
1.57
1.8
1.8
1.3
1.2
mg/l
0.04
202
1755
10
44
2.28
1.53
1.8
3.3
493.0
780.5
u/ml
—
10
44
5
15
3.34
1.52
1.0
1.5
—
—
—
0
0
254
2228
1.18
1.50
4.5
3.8
1.0
1.0
kg/l
1.57
41
313
27
170
1.60
1.49
1.0
1.1
—
—
—
0
0
32
210
1.54
1.49
3.4
3.5
55.7
57.2
%
0.32
32
210
31
202
1.55
1.49
3.5
3.1
3.5
4.3
e9/l
1.91
31
202
9
38
2.38
1.45
1.0
1.3
—
—
—
0
0
12
59
2.04
1.43
1.1
1.4
—
248.3
—
0
6
9
39
2.32
1.43
1.0
1.1
—
—
—
0
0
52
380
1.38
1.42
2.1
1.8
—
—
—
0
0
27
173
1.57
1.41
1.2
1.2
1.3
3.4
u/ml
—
10
54
15
81
1.86
1.40
2.3
2.6
649.5
706.1
e6/l
—
6
32
208
1805
1.18
1.40
3.1
2.9
2.4
2.4
mmol/l
0.74
177
1583
14
74
1.90
1.39
3.1
2.0
—
—
—
0
0
139
1163
1.22
1.38
2.3
2.9
8.0
8.0
umol/l
0.00
119
1009
13
67
1.95
1.38
1.4
1.5
—
—
—
0
0
61
462
1.34
1.35
1.0
1.1
—
1.0
—
0
7
911
8763
1.14
1.35
20.2
16.1
13.6
13.6
%
0.04
897
8571
32
216
1.49
1.34
1.3
1.2
31.9
41.3
u/ml
—
7
19
40
283
1.43
1.33
1.7
1.6
—
—
—
0
0
25
160
1.57
1.32
1.1
1.0
1.0
2.1
u/ml
—
10
70
74
579
1.30
1.31
1.4
1.5
—
—
—
0
0
141
1191
1.21
1.29
3.9
4.2
32.6
31.8
%
0.30
94
826
42
303
1.40
1.26
1.2
1.1
0.6
6.2
u/ml
—
6
37
8
36
2.23
1.24
1.0
1.3
—
—
—
0
0
320
2897
1.14
1.23
4.1
4.0
10.0
8.6
mg/mmol
0.14
203
1813
12
63
1.91
1.23
1.2
1.1
—
—
—
0
0
8
38
2.11
1.18
1.0
1.1
96.8
93.5
%
—
8
33
81
999
0.80
1.18
1.5
1.6
—
—
—
0
0
294
2655
1.14
1.18
1.7
1.7
1.4
1.4
mmol/l
0.27
264
2256
305
2768
1.13
1.13
4.7
4.9
2.0
2.5
ug/l
1.35
275
2482
191
1680
1.16
1.11
1.3
1.2
10.6
13.4
u/ml
0.24
76
649
7
31
2.26
1.10
1.0
1.0
—
—
—
0
0
5
21
2.39
1.09
1.2
1.2
—
—
—
0
0
49
374
1.32
1.07
1.3
1.3
132.6
229.6
miu/ml
1.14
16
179
41
305
1.36
1.06
2.0
2.8
—
—
—
0
0
117
997
1.19
1.01
3.9
3.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
291
1.35
1.00
2.9
3.2
0.4
0.4
u/ml
0.03
19
148
100
841
1.21
0.99
5.3
7.4
8.5
9.0
mmol/l
0.37
93
802
5
23
2.18
0.98
1.0
1.3
—
—
—
0
0
14
84
1.67
0.98
1.1
1.1
—
186.2
—
0
13
91
764
1.21
0.93
3.2
2.5
68.3
69.8
ml/min/173m2
0.11
35
295
6
27
2.23
0.93
1.8
1.1
168.6
1.0
u/ml
—
6
18
25
348
0.71
0.90
1.6
1.5
—
—
—
0
0
36
272
1.33
0.88
3.3
3.8
26.8
31.3
mg/l
0.55
29
216
36
272
1.33
0.88
3.3
3.8
43.6
73.6
mg/l
0.61
29
215
41
316
1.31
0.87
1.9
2.6
3.2
3.2
g/l
0.06
30
250
8
43
1.87
0.87
1.4
3.5
—
—
—
0
0
23
161
1.44
0.87
3.7
5.3
419.8
365.0
umol/l
0.75
18
144
47
370
1.28
0.86
1.6
1.4
—
—
—
0
0
30
221
1.37
0.86
1.1
1.2
0.2
3.1
u/ml
2.41
13
100
287
2641
1.11
0.85
2.7
3.0
1359.8
1225.4
ng/l
0.19
241
2239
25
180
1.40
0.82
1.2
1.3
4.6
6.1
u/ml
—
7
77
119
1037
1.16
0.82
4.4
4.1
254.2
247.9
u/l
0.12
111
984
23
164
1.41
0.80
1.1
1.1
—
—
—
0
0
6
33
1.82
0.79
4.0
2.8
—
—
—
0
0
32
244
1.32
0.76
1.7
1.7
—
—
—
0
0
234
2145
1.11
0.75
1.5
1.6
—
—
—
0
0
29
218
1.34
0.75
2.3
2.2
130.3
131.4
g/l
0.10
19
169
17
116
1.47
0.74
1.5
1.6
63.5
57.6
%
0.24
11
81
24
323
0.74
0.74
1.5
1.4
—
—
—
0
0
16
108
1.49
0.73
1.1
1.2
76.2
64.9
u/l
—
9
76
24
322
0.74
0.73
1.5
1.4
—
—
—
0
0
24
321
0.74
0.71
1.5
1.4
—
—
—
0
0
24
321
0.74
0.71
1.5
1.4
—
—
—
0
0
7
40
1.75
0.71
1.1
1.0
—
—
—
0
0
20
143
1.41
0.70
4.9
3.3
0.9
1.2
%
0.29
14
123
55
455
1.22
0.70
2.1
2.2
3969.9
4865.9
u/l
0.17
21
188
41
328
1.26
0.70
1.1
1.2
—
—
—
0
0
412
3895
1.09
0.69
4.3
3.7
—
—
—
0
0
10
61
1.64
0.68
1.1
1.0
—
—
—
0
0
39
311
1.26
0.68
1.7
2.6
8.8
10.3
g/l
1.30
30
268
18
127
1.42
0.68
1.4
1.3
—
—
—
0
0
11
70
1.58
0.65
2.8
2.8
0.2
0.2
e9/l
0.48
11
62
176
1606
1.11
0.63
2.9
2.9
0.7
0.7
ug/l
0.54
124
1036
8
49
1.64
0.62
1.9
2.6
—
—
—
0
0
26
200
1.31
0.61
3.0
2.3
15.8
16.2
%
0.25
14
112
41
335
1.23
0.60
1.9
2.5
3.6
3.8
g/l
0.20
29
245
44
363
1.22
0.59
1.4
1.5
—
—
—
0
0
8
52
1.54
0.59
1.0
1.3
—
—
—
0
0
0
22
0.00
0.59
0.0
1.6
—
—
—
0
0
41
336
1.23
0.59
1.9
2.5
—
—
—
0
0
41
336
1.23
0.59
1.9
2.5
7.3
7.4
g/l
0.08
31
256
19
140
1.36
0.58
1.8
1.8
—
1552.0
—
0
5
8
53
1.51
0.58
1.1
1.3
—
—
—
0
0
8
53
1.51
0.58
1.1
1.3
—
—
—
0
0
40
328
1.23
0.57
1.1
1.2
—
—
—
0
0
36
292
1.24
0.57
2.0
2.8
0.7
1.0
g/l
0.38
31
261
67
579
1.17
0.56
1.1
1.1
—
—
—
0
0
47
394
1.20
0.55
1.8
2.1
1.3
1.5
g/l
0.57
39
356
87
768
1.14
0.55
2.4
3.0
160.5
179.9
ng/l
0.21
79
706
36
438
0.82
0.55
1.6
1.7
3.0
2.9
mg/l
0.05
21
307
89
788
1.14
0.54
2.0
2.4
10.5
7.2
ug/l
0.35
67
698
25
195
1.29
0.54
1.2
1.5
102.2
105.2
u/ml
—
5
37
117
1295
0.89
0.54
2.1
2.0
—
—
—
0
0
6
100
0.60
0.51
1.5
1.5
—
13.1
—
0
23
6
40
1.50
0.51
1.2
1.3
—
—
—
0
0
78
688
1.14
0.51
1.8
1.7
—
—
—
0
0
33
270
1.23
0.50
1.7
2.6
36.5
37.9
g/l
0.60
28
234
77
680
1.14
0.50
1.5
1.3
302.5
218.5
u/ml
0.23
70
628
236
2214
1.08
0.49
4.5
4.3
22.7
21.2
%
0.72
123
1031
18
136
1.33
0.49
1.0
1.1
—
—
—
0
0
60
521
1.16
0.49
3.8
5.0
23.8
24.2
mmol/l
0.42
53
476
16
119
1.35
0.48
2.7
1.9
31.1
32.5
pg
0.46
16
119
11
76
1.45
0.48
1.1
1.2
—
—
—
0
0
41
346
1.19
0.47
3.4
3.9
1.4
1.4
mmol/l
0.01
41
339
8
120
0.66
0.45
1.0
1.1
—
—
—
0
0
128
1174
1.10
0.45
23.1
23.7
1.2
1.3
inr
0.26
13
158
7
51
1.37
0.44
1.9
1.7
—
—
—
0
0
8
56
1.43
0.42
1.4
2.1
—
—
—
0
0
132
1429
0.91
0.42
2.1
2.1
—
—
—
0
0
5
32
1.56
0.42
1.0
1.6
—
—
—
0
0
5
32
1.56
0.42
1.0
1.1
111.0
94.6
%
—
5
32
5
32
1.56
0.42
1.0
1.1
—
—
—
0
0
8
59
1.36
0.41
1.1
1.2
—
—
—
0
0
191
1793
1.08
0.41
1.4
1.5
—
—
—
0
0
59
521
1.14
0.40
2.4
2.8
65.4
52.7
u/ml
0.13
59
501
25
205
1.22
0.39
1.4
1.8
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
2.8
—
—
—
0
0
102
934
1.10
0.39
3.5
4.3
1.3
1.9
mmol/l
0.99
83
737
102
936
1.10
0.37
3.0
4.3
5.3
23.6
ug/l
1.29
81
768
5
77
0.65
0.35
1.0
1.1
—
—
—
0
0
9
122
0.74
0.35
1.0
1.4
—
—
—
0
0
24
199
1.21
0.35
1.2
1.2
—
7.1
—
0
16
38
331
1.15
0.33
1.8
1.6
0.2
0.1
iu/ml
—
6
57
35
304
1.16
0.32
1.1
1.1
—
—
—
0
0
7
52
1.35
0.31
1.9
1.7
—
—
—
0
0
27
230
1.18
0.31
1.3
1.2
—
—
—
0
0
32
278
1.16
0.29
1.4
1.5
—
—
—
0
0
16
130
1.23
0.28
1.5
1.6
—
—
—
0
0
14
173
0.81
0.28
1.0
1.1
—
—
—
0
0
10
129
0.77
0.28
1.2
1.1
—
—
—
0
0
10
76
1.32
0.28
1.0
1.6
0.9
1.0
g/l
—
10
76
11
85
1.30
0.28
1.1
1.4
—
—
—
0
0
9
118
0.76
0.27
2.3
1.8
—
—
—
0
0
9
119
0.75
0.27
1.0
1.5
—
—
—
0
0
9
119
0.75
0.27
1.0
1.5
—
—
—
0
0
9
120
0.75
0.27
1.0
1.4
—
—
—
0
0
9
120
0.75
0.27
1.0
1.5
—
—
—
0
0
30
262
1.15
0.26
1.4
1.4
—
—
—
0
0
10
77
1.30
0.26
1.2
1.3
—
—
—
0
0
12
96
1.25
0.24
1.6
1.3
61840.0
206473.1
e6/l
—
5
63
10
78
1.28
0.24
1.2
1.3
—
—
—
0
0
15
124
1.21
0.24
1.1
1.3
—
0.5
nmol/l
—
0
10
26
227
1.15
0.24
1.4
3.3
26.8
34.5
umol/l
2.24
21
190
14
115
1.22
0.23
1.4
1.7
—
—
—
0
0
49
447
1.10
0.23
2.8
3.1
25.5
25.3
mmol/l
0.25
49
426
5
38
1.32
0.23
1.4
1.9
—
—
—
0
0
5
38
1.32
0.23
1.4
1.9
—
—
—
0
0
5
39
1.28
0.23
1.4
1.9
—
—
—
0
0
11
88
1.25
0.22
1.7
1.3
143210.2
44011.1
e6/l
—
5
48
98
924
1.07
0.22
1.8
2.4
0.2
0.2
g/l
0.02
91
871
14
167
0.84
0.21
1.1
1.3
—
—
—
0
0
13
156
0.83
0.21
2.0
1.2
16.4
36.3
u/l
0.94
13
137
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
12
145
0.83
0.21
2.0
2.1
13.3
13.2
%
0.11
12
145
15
177
0.85
0.21
2.0
1.8
—
—
—
0
0
37
407
0.91
0.20
2.3
1.8
—
—
—
0
0
25
221
1.13
0.20
1.3
1.2
222.5
261.9
u/ml
—
10
130
6
49
1.23
0.20
1.3
1.3
22.4
28.9
nmol/l
—
6
39
38
346
1.10
0.19
1.3
1.3
—
—
—
0
0
6
51
1.18
0.19
1.0
1.0
143.0
180.6
iu/ml
—
6
51
10
122
0.82
0.19
1.1
1.4
—
—
—
0
0
10
81
1.24
0.18
2.6
2.4
—
—
—
0
0
64
599
1.07
0.18
1.2
1.4
—
—
—
0
0
21
237
0.88
0.17
1.7
1.7
—
—
—
0
0
25
224
1.12
0.17
1.5
1.7
—
—
—
0
0
7
63
1.11
0.17
1.9
1.6
—
—
—
0
0
15
129
1.16
0.17
1.0
1.0
0.0
0.7
u/ml
—
5
33
17
148
1.15
0.17
1.5
1.5
—
—
—
0
0
19
167
1.14
0.17
1.4
1.5
—
—
—
0
0
8
72
1.11
0.16
1.1
1.1
—
2.2
—
0
5
9
82
1.10
0.15
1.2
1.2
—
—
—
0
0
12
139
0.86
0.14
1.2
1.1
—
—
—
0
0
24
218
1.10
0.13
1.6
1.4
—
—
—
0
0
84
805
1.05
0.13
2.2
1.9
—
—
—
0
0
25
230
1.09
0.11
2.5
2.5
10.2
123.8
ug/min
3.93
12
139
10
86
1.16
0.11
2.9
2.5
—
—
—
0
0
28
260
1.08
0.11
1.2
1.3
—
—
—
0
0
5
44
1.14
0.10
1.0
1.0
2043.2
1691.5
miu/ml
—
5
44
5
46
1.09
0.09
1.0
1.0
—
—
—
0
0
35
331
1.06
0.09
1.4
1.5
1.2
1.2
g/l
0.17
35
312
19
206
0.92
0.08
1.2
1.5
—
—
—
0
0
6
56
1.07
0.08
1.2
1.2
11.8
11.1
u/l
—
6
51
6
56
1.07
0.08
1.0
1.2
104.1
95.6
u/l
—
6
45
5
61
0.82
0.08
1.0
1.3
—
—
—
0
0
16
146
1.10
0.08
2.4
2.8
7.2
9.1
umol/l
—
9
105
7
64
1.09
0.08
1.3
1.5
—
—
—
0
0
7
68
1.03
0.08
2.0
2.4
—
—
—
0
0
8
75
1.07
0.07
1.3
1.1
—
—
—
0
0
8
75
1.07
0.07
1.3
1.1
—
—
—
0
0
24
225
1.07
0.07
2.8
3.6
22.5
27.3
mg/l
0.28
13
145
8
76
1.05
0.07
1.3
1.1
—
—
—
0
0
8
76
1.05
0.07
1.3
1.1
—
—
—
0
0
8
76
1.05
0.07
1.3
1.1
—
—
—
0
0
8
76
1.05
0.07
1.1
1.5
—
—
—
0
0
8
77
1.04
0.07
1.1
1.1
—
47.5
—
0
6
23
245
0.94
0.07
1.7
1.7
—
—
—
0
0
7
80
0.87
0.07
1.0
1.2
—
—
—
0
0
17
157
1.08
0.07
1.7
3.0
—
480.6
—
0
13
9
88
1.02
0.07
1.2
1.8
7.3
7.9
mmol/l
—
9
54
10
89
1.12
0.07
1.0
1.1
—
—
—
0
0
21
224
0.94
0.06
1.3
1.4
—
—
—
0
0
66
641
1.03
0.06
2.1
1.8
—
—
—
0
0
9
105
0.86
0.06
2.6
3.9
—
—
—
0
0
37
355
1.04
0.06
3.8
3.4
3242.0
3911.0
u/ml
0.06
32
310
31
324
0.96
0.05
2.2
1.7
—
—
—
0
0
10
90
1.11
0.05
1.2
1.4
2.0
1.4
nmol/l
—
10
80
27
257
1.05
0.05
1.1
1.2
—
—
—
0
0
37
382
0.97
0.04
1.4
1.5
—
—
—
0
0
11
119
0.92
0.04
1.9
2.6
106.2
105.6
mmol/l
0.22
11
119
11
119
0.92
0.04
1.9
2.6
4.0
4.0
mmol/l
0.16
11
119
14
131
1.07
0.03
1.6
1.6
—
—
—
0
0
38
369
1.03
0.03
2.0
1.8
2.6
2.0
ug/l
0.10
27
330
17
161
1.06
0.03
1.2
1.1
50.3
106.4
iu/ml
—
5
40
11
102
1.08
0.03
1.0
1.3
—
—
—
0
0
15
142
1.06
0.02
1.7
2.5
4.4
33.0
u/ml
0.51
15
132
16
168
0.95
0.02
1.6
1.5
—
—
—
0
0
58
587
0.99
0.01
1.3
1.5
—
—
—
0
0
15
149
1.01
0.00
1.9
1.7
—
—
—
0
0
31
309
1.00
0.00
1.4
1.3
—
—
—
0
0
10
103
0.97
0.00
1.5
1.8
—
—
—
0
0
16
157
1.02
0.00
1.1
1.2
—
—
—
0
0
24
237
1.01
0.00
1.5
1.6
13295.5
12810.9
e6/l
0.03
17
174
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
8
86
0.93
0.00
1.4
1.6
—
—
—
0
0
5
50
1.00
0.00
1.4
1.7
—
—
—
0
0
36
360
1.00
0.00
1.6
1.8
—
—
—
0
0
8
86
0.93
0.00
1.4
1.6
—
—
—
0
0
5
50
1.00
0.00
1.4
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
50
1.00
0.00
1.4
1.7
—
—
—
0
0
8
86
0.93
0.00
1.4
1.6
—
—
—
0
0
5
50
1.00
0.00
1.2
1.7
—
—
—
0
0
26
260
1.00
0.00
2.8
2.5
24.8
24.9
mmol/l
0.03
21
229
42
420
1.00
0.00
3.6
3.5
53.7
48.0
%
0.61
42
413
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
5.5
—
0
6
7
75
0.93
0.00
2.7
1.8
—
—
—
0
0
7
79
0.89
0.00
1.3
1.7
—
—
—
0
0
19
190
1.00
0.00
1.5
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
5.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H7_VERTISTRAB and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_VERTISTRAB | 0.921 [0.77, 1.09] | 0.349 |
| Birth year | 0.992 [0.98, 1.0] | 0.078 |
During the follow-up period (1.1.1998 — 31.12.2019), 229 out of 3370 females with H7_VERTISTRAB died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_VERTISTRAB | 1.046 [0.89, 1.23] | 0.586 |
| Birth year | 0.987 [0.98, 1.0] | 0.007 |
During the follow-up period (1.1.1998 — 31.12.2019), 278 out of 2894 males with H7_VERTISTRAB died.
Mortality risk
Mortality risk for people of age
years, who have H7_VERTISTRAB.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.086% | 0.209% |
| 5 | 0.507% | 1.234% |
| 10 | 1.248% | 2.985% |
| 15 | 2.428% | 5.589% |
| 20 | 4.468% | 9.332% |
Relationships between endpoints
↥Index endpoint: H7_VERTISTRAB – Vertical strabismus
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data